Combination of PD-1 antagonists and Lag3 antagonists for treatment of superior colorectal cancer with non microsatellite high instability / mismatch repair

摘要

This disclosure is a combination therapy of antagonists of the programmed death 1 receptor (PD-1) and antagonists of lymphocyte activating gene 3 (Lag3), including Describes the use of combinatorial therapy for treatment of colorectal cancer (CRC) in non microsatellite high instability (non MSI-H) or mismatch repair (PMMR).Diagram